For Fragments Based Innovations
 
 
 
 
Products
Entire Product List
Structure Product Information
AKD005
Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, (16,17)-
[146-48-5]
AKP001
1H,5H,10H-Dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one, dodecahydro-, (7aS,13aR,13bR,13cS)-
[519-02-8]
AKP002
1H,5H,10H-Dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one, dodecahydro-, 4-oxide, (4R,7aS,13aR,13bR,13cS)-
[16837-52-8]
AKP003
1H,5H,10H-Dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one, 2,3,6,7,7a,8,13,13a,13b,13c-decahydro-, (7aS,13aR,13bR,13cS)-
[6483-15-4]
AKP004
1H,5H,10H-Dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one, dodecahydro-, (7aR,13aR,13bR,13cS)-
[6882-68-4]
AKP005
1H,5H,10H-Dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one, dodecahydro-, 4-oxide, (7aR,13aR,13bR,13cS)-
[54809-74-4]
AKP016
3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2R,3R,4R,5S)-
[19130-96-2]
AKQ010
Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium, 5,6-dihydro-9,10-dimethoxy-
[2086-83-1]
AKQ011
6H-Dibenzo[a,g]quinolizine, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-, hydrochloride (1:1)
[6024-85-7]
AKQ012
Dibenzo[a,g]quinolizinium, 5,6-dihydro-2,3,9,10-tetramethoxy-, chloride (1:1)
[10605-02-4]
AKQ024
Morphinan-6-one, 7,8-didehydro-4-hydroxy-3,7-dimethoxy-17-methyl-, (9,13,14)-
[115-53-7]
AQA002
9,10-Anthracenedione, 1,8-dihydroxy-3-methyl-
[481-74-3]
AQA003
9,10-Anthracenedione, 1,8-dihydroxy-3-(hydroxymethyl)-
[481-72-1]
AQA004
9(10H)-Anthracenone, 10--D-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-, (10R)-
[28371-16-6]
AQA005
9,10-Anthracenedione, 1,3,8-trihydroxy-6-methyl-
[518-82-1]
AQP002
Phenanthro[1,2-b]furan-10,11-dione, 1,6-dimethyl-
[568-73-0]
AQP004
Phenanthro[1,2-b]furan-10,11-dione, 1,2,6,7,8,9-hexahydro-1,6,6-trimethyl-, (1R)-
[35825-57-1]
CMR002
2H-1-Benzopyran-2-one, 6-(-D-glucopyranosyloxy)-7-hydroxy-
[531-75-9]
CMR016
7H-Furo[3,2-g][1]benzopyran-7-one, 4-methoxy-
[484-20-8]
FLA001
2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R,3S)-
[154-23-4]
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk. 
Page [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127]

 


New Arrival

Copyright © 2010-2015 Fragmenta. All rights reserved.  Terms of Use | Order and Payment Terms | Help